Emily H. Cheng
- Molecular Biology top 0.2%
- Oncology top 1%
- Cancer Research top 0.5%
- Epidemiology top 1%
- Immunology top 1%
- Co-authors
- Stanley J. KorsmeyerJames J. HsiehTullia LindstenMichael C. WeiCraig B. ThompsonJ. Marie HardwickWei‐Xing ZongGrant R. MacGregor
- Topics
- Cell death mechanisms and regulation (32 papers)Renal cell carcinoma treatment (16 papers)Cancer Genomics and Diagnostics (15 papers)
- Partner nations
- United StatesJapanSpain
In The Last Decade
Emily H. Cheng
94 papers receiving 16.2k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Molecular Biology 12.6k
- Oncology 2.6k
- Cancer Research 2.5k
- Epidemiology 2.3k
- Immunology 2.1k
Countries citing papers authored by Emily H. Cheng
This map shows the geographic impact of Emily H. Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily H. Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily H. Cheng more than expected).
Fields of papers citing papers by Emily H. Cheng
This network shows the impact of papers produced by Emily H. Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily H. Cheng. The network helps show where Emily H. Cheng may publish in the future.
Co-authorship network of co-authors of Emily H. Cheng
This figure shows the co-authorship network connecting the top 25 collaborators of Emily H. Cheng. A scholar is included among the top collaborators of Emily H. Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily H. Cheng. Emily H. Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 55 | |
| 2 | 77 | |
| 3 | 77 | |
| 4 | An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinomabreakdown → | 531 |
| 5 | 8 | |
| 6 | 23 | |
| 7 | 156 | |
| 8 | 25 | |
| 9 | 267 | |
| 10 | 51 | |
| 11 | 35 | |
| 12 | 45 | |
| 13 | 174 | |
| 14 | 35 | |
| 15 | 29 | |
| 16 | 378 | |
| 17 | 113 | |
| 18 | 477 | |
| 19 | 55 | |
| 20 | 99 |
About Emily H. Cheng
Emily H. Cheng is a scholar working on Cancer Research, Molecular Biology and Hematology, having authored 94 papers that have together received 16.4k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (32 papers), Renal cell carcinoma treatment (16 papers) and Cancer Genomics and Diagnostics (15 papers). The work is most often cited by research in Molecular Biology (12.6k citations), Cancer Research (2.5k citations) and Cell Biology (1.8k citations). Emily H. Cheng has collaborated with scholars based in United States, Japan and Spain. Frequent co-authors include Stanley J. Korsmeyer, James J. Hsieh, Tullia Lindsten, Michael C. Wei, Craig B. Thompson, J. Marie Hardwick, Wei‐Xing Zong, Grant R. MacGregor, Vily Panoutsakopoulou and Kevin A. Roth. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.